Phase II Trial of Neoadjuvant Bevacizumab, Capecitabine, and Radiotherapy for Locally Advanced Rectal Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 76, Issue 3, 2010, Pages 824-830

  Crane, Christopher H ^a   Eng, Cathy ^a   Feig, Barry W ^a   Das, Prajnan ^a   Skibber, John M ^a   Chang, George J ^a   Wolff, Robert A ^a   Krishnan, Sunil ^a   Hamilton, Stanley ^a   Janjan, Nora A ^a   Maru, Dipen M ^a   Ellis, Lee M ^a   Rodriguez Bigas, Miguel A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Bevacizumab; Chemoradiation; Neoadjuvant; Rectal cancer

Indexed keywords

ACUTE TOXICITY; BEVACIZUMAB; CAPECITABINE; CHEMORADIATION; GASTROINTESTINAL TOXICITIES; HEMATOLOGIC TOXICITY; NEOADJUVANT CHEMORADIATION; NEOADJUVANT THERAPY; PATHOLOGIC COMPLETE RESPONSE; PHASE II; RECTAL CANCER; SURGICAL INTERVENTIONS; SURGICAL RESECTION; TUMOR CELLS;

DESIGN; TOXICITY;

RADIOTHERAPY;

BEVACIZUMAB; CAPECITABINE; OXALIPLATIN;

ADD ON THERAPY; ADULT; ADVANCED CANCER; AGED; ANASTOMOSIS; ANEMIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FATIGUE; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HAND FOOT SYNDROME; HUMAN; HYPERTENSION; INTESTINE PERFORATION; LUNG EMBOLISM; MALE; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM CANCER; RECTUM RESECTION; THROMBOCYTOPENIA; THROMBOEMBOLISM; TREATMENT RESPONSE; TUMOR CELL; WOUND COMPLICATION; WOUND DEHISCENCE; WOUND HEALING;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; DEOXYCYTIDINE; DOSE FRACTIONATION; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; RECTAL NEOPLASMS; SURGICAL WOUND DEHISCENCE;

EID: 76049088643     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.02.037     Document Type: Article

References (24)

1. Prolongation of the disease-free interval in surgically treated rectal carcinoma. Gastrointestinal Tumor Study Group. N Engl J Med 312 (1985) 1465-1472
2. Krook J.E., Moertel C.G., Gunderson L.L., et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. [see comments]. N Engl J Med 324 (1991) 709-715 1991
3. Bosset J.F., Collette L., Calais G., et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355 (2006) 1114-1123
4. Gérard J.-P., Conroy T., Bonnetain F., et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in t3-4 rectal cancers: Results of FFCD 9203. J Clin Oncol 24 (2006) 4620-4625
5. Sauer R., Becker H., Hohenberger W., et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. [see comment]. N Engl J Med 351 (2004) 1731-1740
6. Crane C. The promises and potential pitfalls of organ preservation for locally advanced rectal cancer. Ann Surg Oncol 3 (2006) 288-290
7. Willett C., Duda D., Boucher Y., et al. Phase I/II study of neoadjuvant bevacizumab with radiation therapy and 5-fluorouracil in patients with rectal cancer: Initial results. ASCO Annual Meeting Proceedings, Part I. J Clin Oncol 25 (2007) Abst 4041
8. Willett C.G., Boucher Y., Duda D.G., et al. Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: Continued experience of a phase I trial in rectal cancer patients. J Clin Oncol 23 (2005) 8136-8139
9. Crane C.H., Ellis L.M., Abbruzzese J.L., et al. Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer. J Clin Oncol 24 (2006) 1145-1151
10. American Joint Committee on Cancer. AJCC cancer staging manual. 6th ed. (2002), Springer, New York 157-164
11. Bonnen M., Crane C., Vauthey J.-N., et al. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients. Int J Radiat Oncol Biol Phys 60 (2004) 1098-1105
12. Gunderson L.L., Sargent D.J., Tepper J.E., et al. Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: A pooled analysis. J Clin Oncol 22 (2004) 1785-1796
13. Hermann R.M., Rave-Fränk M., and Pradier O. Combining radiation with oxaliplatin: A review of experimental results. Cancer/Radiother 12 (2008) 61-67
14. Kirichenko A.V., and Rich T.A. Radiation enhancement by 9-aminocamptothecin: The effect of fractionation and timing of administration. Int JRadiat Oncol Biol Phys 44 (1999) 659-664
15. Aranha O., and Benson III A.B. Adjuvant therapy for colon cancer. Curr Gastroenterol Rep 9 (2007) 15-21
16. Das P., Lin E.H., Bhatia S., et al. Neoadjuvant chemoradiation with capecitabine versus infusional 5-fluorouracil (5-FU) for locally advanced rectal cancer: A matched pair analysis. Int J Radiat Oncol Biol Phys 63 (2005) S164
17. Rosenthal D.I., Catalano P.J., Haller D.G., et al. Phase I study of preoperative radiation therapy with concurrent infusional 5-fluorouracil and oxaliplatin followed by surgery and postoperative 5-fluorouracil plus leucovorin for t3/t4 rectal adenocarcinoma: ECOG E1297. Int J Radiat Oncol Biol Phys 72 (2008) 108-113
18. Bonner J.A., Harari P.M., Giralt J., et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354 (2006) 567-578
19. Czito B., Willett C., and Bendell J. Combined-modality therapy for rectal cancer: Future prospects. Clin Colorectal Cancer 6 (2007) 625-633
20. Mehta V.K., Cho C., Ford J.M., et al. Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11, followed by surgery for ultrasound-staged T3 rectal cancer. Int J Radiat Oncol Biol Phys 55 (2003) 132-137
21. Mohiuddin M., Winter K., Mitchell E., et al. Randomized Phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012. J Clin Oncol 24 (2006) 650-655
22. Påhlman L. Initial report from a Swedish multicentre study examining the role of preoperative irradiation in the treatment of patients with resectable rectal carcinoma. Br J Surg 80 (2005) 1333-1336
23. Nissan A., Guillem J., Paty P., et al. Abdominoperineal resection for rectal cancer at a specialty center. Dis Colon Rectum 44 (2001) 27-35
24. Czito B.G., Bendell J.C., Willett C.G., et al. Bevacizumab, oxaliplatin, and capecitabine with radiation therapy in rectal cancer: Phase I trial results. Int J Radiat Oncol Biol Phys 68 (2007) 472-478